Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions

Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions

Purpose: Neurogenic lower urinary tract dysfunction (NLUTD) is common in patients with neurological lesions in the central nervous system (CNS). Medical treatment usually cannot adequately relieve NLUTD. This study reported the real-life treatment outcome of botulinum toxin A (BoNT-A) for overactive...

Full description

Bibliographic Details
Main Authors:	Yuan-Hong Jiang, Jia-Fong Jhang, Sheng-Fu Chen, Hann-Chorng Kuo
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Toxins
Subjects:	lower urinary tract dysfunction overactive bladder dysfunctional voiding neurogenic bladder botulinum toxin A
Online Access:	https://www.mdpi.com/2072-6651/16/3/123

Similar Items

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
by: Yuan-Hong Jiang, et al.
Published: (2023-01-01)

Efficacy of Intravesical Botulinum Toxin A Injection in the Treatment of Refractory Overactive Bladder in Children
by: Yu-Hua Fan, et al.
Published: (2023-03-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome
by: Chun-Hou Liao, et al.
Published: (2015-12-01)

The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A
by: Chung-Cheng Wang, et al.
Published: (2020-03-01)

The application of botulinum toxin in the treatment of overactive bladder
by: Justyna Wojcik, et al.
Published: (2020-09-01)

Intravesical Injection of Botulinum Toxin Type A in Men without Bladder Outlet Obstruction and Post-Deobstructive Prostate Surgery
by: Hsiang-Ying Lee, et al.
Published: (2023-03-01)

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
by: Hann-Chorng Kuo
Published: (2020-06-01)

The challenge of overactive bladder therapy: alternative to antimuscarinic agents
by: Massimo Lazzeri, et al.
Published: (2006-12-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

Real-World Data Regarding Satisfaction to Botulinum Toxin A Injection into the Urethral Sphincter and Further Bladder Management for Voiding Dysfunction among Patients with Spinal Cord Injury and Voiding Dysfunction
by: Cheng-Ling Lee, et al.
Published: (2022-01-01)

Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Perioperative Techniques for the Use of Botulinum Toxin in Overactive Bladder: Results of a Multinational Online Survey of Urogynecologists in Germany, Austria, and Switzerland
by: Sören Lange, et al.
Published: (2023-02-01)

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
by: Agnieszka A. Licow-Kamińska, et al.
Published: (2023-12-01)

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder
by: Naoki Wada, et al.
Published: (2022-09-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

Efficacy of botulinum toxin type A 100 units versus 200 units for treatment of refractory idiopathic overactive bladder
by: Osama Abdelwahab, et al.
Published: (2015-12-01)

Botulinum Toxin in Neurogenic Detrusor Overactivity
by: Carlos Arturo Levi D'Ancona, et al.
Published: (2012-09-01)

Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders
by: Fan-Ching Hung, et al.
Published: (2022-12-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Experience with different botulinum toxins for the treatment of refractory neurogenic detrusor overactivity
by: Cristiano M. Gomes, et al.
Published: (2010-02-01)

Botulinum Toxin Injection for Medically Refractory Neurogenic Bladder in Children: A Systematic Review
by: Shu-Yu Wu, et al.
Published: (2021-06-01)

Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder—Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes
by: Yin-Chien Ou, et al.
Published: (2023-01-01)

Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction
by: Joseph J. Janicki, et al.
Published: (2016-03-01)

Neuro-Urology: Call for Universal, Resource-Independent Guidance
by: Glenn T. Werneburg, et al.
Published: (2023-01-01)

Botulinum toxin: An emerging therapy in female bladder outlet obstruction
by: Aditya A Pradhan
Published: (2009-01-01)

Abobotulinum - a toxin injection in patients with refractory idiopathic detrusor overactivity: injections in detrusor, trigone and bladder neck or prostatic urethra, versus detrusor - only injections
by: Maryam Emami, et al.

ONABOTULINUM TOXIN-A FOR OVERACTIVE BLADDER
by: Mahmood Shakir Abdulkarim
Published: (2016-12-01)

The use of botulinum toxin (BoNT) in urology - review
by: Jakub Szwed, et al.
Published: (2022-08-01)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
by: Yuan-Hong Jiang, et al.
Published: (2020-12-01)

Transurethral Incision of the Bladder Neck with or without Additional Procedure Resumes Spontaneous Voiding in Female Voiding Dysfunction—A Long-Term Retrospective Follow-Up
by: Hueih-Ling Ong, et al.
Published: (2023-02-01)

Satisfaction with Detrusor OnabotulinumtoxinA Injections and Conversion to Other Bladder Management in Patients with Chronic Spinal Cord Injury
by: Sheng-Fu Chen, et al.
Published: (2022-01-01)

Onabotulinum Toxin A Intradetrusor Injections in Children with Neurogenic Lower Urinary Tract Dysfunction: Long-Term Histological Effects on the Bladder Wall
by: Chiara Pellegrino, et al.
Published: (2023-04-01)

Recurrent urinary tract infection in women and overactive bladder – Is there a relationship?
by: Qian-Sheng Ke, et al.
Published: (2021-01-01)

Predictive Factors for a Successful Treatment Outcome in Patients with Different Voiding Dysfunction Subtypes Who Received Urethral Sphincter Botulinum Injection
by: Yao-Lin Kao, et al.
Published: (2022-12-01)

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
by: Jia-Fong Jhang, et al.
Published: (2016-04-01)

Therapeutic Efficacy of Urethral Sphincteric Botulinum Toxin Injections for Female Sphincter Dysfunctions and a Search for Predictive Factors
by: Yin-Chien Ou, et al.
Published: (2021-06-01)

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature
by: David C. Moore, et al.
Published: (2016-03-01)